Literature DB >> 17896298

What do different visual function questionnaires measure?

Robert W Massof1, Lohrasb Ahmadian.   

Abstract

PURPOSE: There are dozens of visual function questionnaires (VFQs). VFQs differ in number of items, item content, and response categories. Despite differences, all VFQs are designed to measure vision-related functional ability in visually impaired people. The objective is to determine whether four popular VFQs measure the same variable in visually impaired patients.
METHODS: Two of four VFQs (ADVS, NEI-VFQ, VF-14, VAQ) plus the SF-36 were administered by telephone to 407 consecutive low vision clinic patients. Thus, each instrument was administered to just over 200 patients, and there were over 67 patients for each of the 6 pairings of VFQs. Separate Rasch analyses were performed on patient responses to each VFQ and to the physical and mental health domains in the SF-36.
RESULTS: Person measure estimates from the four VFQs were highly correlated. Person measures estimated from the mental health and physical domains of the SF-36 were uncorrelated with each other and with person measures estimated from the VFQs. From principal components analysis we concluded that three factors were necessary and sufficient: the first principal component accounts for 62% of the variance, the other two factors account for 16% and 14% of the variance, respectively. The VFQs load most heavily on the first factor; the mental health component of the SF-36 loads most heavily on the second; and the physical limitations component of the SF-36 loads most heavily on the third.
CONCLUSIONS: The four VFQs measure the same vision-related functional ability variable in low vision patients that is separate from and independent of the physical and mental health variables measured by the SF-36.

Entities:  

Mesh:

Year:  2007        PMID: 17896298     DOI: 10.1080/09286580701487883

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  8 in total

1.  Is the pediatric quality of life inventory valid for use in preschool children with refractive errors?

Authors:  Ecosse L Lamoureux; Manjula Marella; Benjamin Chang; Mohamed Dirani; Au Eong Kah-Guan; Audrey Chia; Terry L Young; Tien Y Wong; Seang Mei Saw
Journal:  Optom Vis Sci       Date:  2010-11       Impact factor: 1.973

2.  Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes.

Authors:  Yannis M Paulus; Joan L Jefferys; Barbara S Hawkins; Adrienne W Scott
Journal:  Qual Life Res       Date:  2017-03-29       Impact factor: 4.147

3.  Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER Taskforce.

Authors:  Lauren N Ayton; Joseph F Rizzo; Ian L Bailey; August Colenbrander; Gislin Dagnelie; Duane R Geruschat; Philip C Hessburg; Chris D McCarthy; Matthew A Petoe; Gary S Rubin; Philip R Troyk
Journal:  Transl Vis Sci Technol       Date:  2020-07-16       Impact factor: 3.283

4.  Associations between self-rated vision score, vision tests, and self-reported visual function in the Salisbury Eye Evaluation Study.

Authors:  Mahmood El-Gasim; Beatriz Munoz; Sheila K West; Adrienne W Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-27       Impact factor: 4.799

Review 5.  An update on retinal prostheses.

Authors:  Lauren N Ayton; Nick Barnes; Gislin Dagnelie; Takashi Fujikado; Georges Goetz; Ralf Hornig; Bryan W Jones; Mahiul M K Muqit; Daniel L Rathbun; Katarina Stingl; James D Weiland; Matthew A Petoe
Journal:  Clin Neurophysiol       Date:  2019-12-10       Impact factor: 3.708

6.  Development of the Ultra-Low Vision Visual Functioning Questionnaire (ULV-VFQ).

Authors:  Pamela E Jeter; Collin Rozanski; Robert Massof; Olukemi Adeyemo; Gislin Dagnelie
Journal:  Transl Vis Sci Technol       Date:  2017-05-31       Impact factor: 3.283

7.  A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene Therapy.

Authors:  Tomas S Aleman; Alexander J Miller; Katherine H Maguire; Elena M Aleman; Leona W Serrano; Keli B O'Connor; Emma C Bedoukian; Bart P Leroy; Albert M Maguire; Jean Bennett
Journal:  Clin Ophthalmol       Date:  2021-03-02

8.  Psychometric properties of the Greek version of the NEI-VFQ 25.

Authors:  Georgios Labiris; Andreas Katsanos; Michael Fanariotis; Theodora Tsirouki; Maria Pefkianaki; Dimitrios Chatzoulis; Evangelia Tsironi
Journal:  BMC Ophthalmol       Date:  2008-03-06       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.